Media Room
latest news
Multiple Alliance Members Co-sign the Canadian Declaration on Antimicrobial Resistance
The International Council of Biotechnology Associations (ICBA) supports the Canadian Declaration on Combatting Antimicrobial Resistance, signed by biopharmaceutical and diagnostic companies in Canada...
Read more
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The re...
Read more
New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance
New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance....
Read morefrom the blog
Drugs companies are rising to the challenges of research into superbugs
This letter was first published on the Financial Times on 4th July 2018, in response to the article titled "Pharma sector failing to tackle superbugs, says O’Neill" (26th June 2018) I respectful...
Read more
Accelerating the development and delivery of new innovations for a TB-free world
Before the World Economic Forum, Davos’ first claim to fame was as a haven for wealthy tuberculosis sufferers in the 1800s and 1900s: the rarefied air of the Magic Mountain, as Thomas Mann dubbed it...
Read more
A Frightening Reality
From a sustainable antibiotics perspective, 2018 is not wasting time getting to the point. The new year has kicked off with tremendous momentum in the fight against antimicrobial resistance (AMR), wit...
Read morein the press
Pharmaceuticals in the Environment
This article was published on PharmTech on 2 August, 2018 (Pharmaceutical Technology, Volume 42, Issue 8). Content by Sean Milmo. "An Antimicrobial Resistance (AMR) Industry Allian...
Read more
Antimicrobial resistance and vaccines – Life science industry makes the link and drives progress
This Q&A was first published on PharmExec on 20 April, 2018. Interview by Julian Upton. 1. When trying to reduce antimicrobial resistance, how can vaccines help? Vaccines are critical and po...
Read more
NZZ – We need a sustainable business model
This interview was first published on NZZ on 24 February 2018. Interview by Birgit Voigt. NZZ on Sunday: Why is the pharmaceutical industry not developing more new antibiotics? Thomas Cueni: Today...
Read more